An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

NCT00076635 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

91

Enrollment

INDUSTRY

Sponsor class

Stopped program discontinued based on GIPF-007 results

Conditions

Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis
Lung Disease

Interventions

DRUG: Interferon gamma-1b

Sponsor

InterMune